What is Generate Biomedicines, Inc. 's other income (expense)?

Generate Biomedicines, Inc. (GENB) reported other income (expense) of $2.43M in Q1 2026.

What does other income (expense) mean?

Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Generate Biomedicines, Inc. GENB Other Income (Expense)

Other Income (Expense) at other companies

MYR GroupMYRG

-$948K-216%

SSR MiningSSRM

$9.58M+918%

NNN REITNNN

-$52.7M-11.2%

RepligenRGEN

-$14.17M-1,138%

Enact Holdings, Inc.ACT

$4.14M+88.3%

RayonierRYN

$854K+146%

Other financials

Income statement

See full

Revenue$7.2M-18.1%

Operating income-$64.1M-33.1%

Net income-$61.4M-47.4%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total equity$514.8M+209%

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Debt / equity0.1×—

Current ratio9.2×—

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's other income (expense)?: Generate Biomedicines, Inc. (GENB) reported other income (expense) of $2.43M in Q1 2026.
What does other income (expense) mean?: Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.